Achieve maximum impact
Assays

Achieve maximum impact
in testing for SARS-CoV-2

The BD SARS-CoV-2 Reagents for BD MAX™ System provides rapid molecular testing for the detection of SARS-CoV-2 in about 2 hours

Help manage the pandemic
Maximise performance
Maximise
efficiency

Ability to test ample portions of the population, do contact tracing and enforce isolation of those who have been infected is key for containing the spread of SARS-CoV-21

  • The COVID-19 pandemic continues to impact Europe as countries work to manage testing and transmission control of this infectious virus
24 Million confirmed
~ 24 Million confirmed
 cases of COVID-19

globally in only 9 months2
827,246 deaths
~ 827,246 deaths
from COVID-19

globally in only 9 months2

Molecular testing can play an important role in controlling the SARS-CoV-2 transmission3

  • The BD SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test designed to detect SARS-CoV-2 in nasal, nasopharyngeal and oropharyngeal swabs samples from individuals suspected of COVID-19 by their healthcare provider4
  • The assay utilizes multiplexed primers and probes targeting RNA from the nucleocapsid phosphoprotein gene (N1 and N2 regions) of the SARS-CoV-2 coronavirus, and the human RNase P gene4

The BD SARS-CoV-2 Reagents for BD MAX™ System is a fully integrated solution to help you achieve clinical efficiency

  • Simplified and automated workflow
  • Pre-loaded unitized reagent strips
  • Run up to 24 samples at a time
  • Results in about 2 hours
Fast time to result
Fast time
to result
Workflow efficiency
Workflow
efficiency
Supports patient management
Supports patient
management

The BD SARS-CoV-2 assay is fully integrated
on the BD MAX™ System

Discover BD’s full Respiratory Infections Portfolio